Understanding how brain cells manage protein buildup in neurodegenerative diseases

Astrocyte-neuron regulation of autophagy and lysosomal pathways in proteotoxic stress associated with alpha-synucleinopathies

['FUNDING_R21'] · UNIVERSITY OF PENNSYLVANIA · NIH-11162530

This study looks at how two types of brain cells, neurons and astrocytes, deal with harmful proteins that can build up in diseases like Alzheimer's and Parkinson's, hoping to find new ways to help improve brain health and treatment options for patients.

Quick facts

Phase['FUNDING_R21']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF PENNSYLVANIA (nih funded)
Locations1 site (PHILADELPHIA, UNITED STATES)
Trial IDNIH-11162530 on ClinicalTrials.gov

What this research studies

This research investigates the differences in how neurons and astrocytes, two types of brain cells, handle the accumulation of misfolded proteins associated with neurodegenerative diseases like Alzheimer's and Parkinson's. The study aims to explore the mechanisms of autophagy and lysosomal pathways in these cells to understand their roles in maintaining protein health. By examining how these pathways function differently in neurons and astrocytes, the research seeks to uncover potential therapeutic targets for treating these conditions. Patients may benefit from insights that could lead to new treatments aimed at improving brain health and function.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with age-related neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, or similar conditions.

Not a fit: Patients with neurodegenerative diseases not related to protein misfolding or those with acute neurological conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases by enhancing the brain's ability to manage protein buildup.

How similar studies have performed: Previous research has shown promising results in understanding the role of cellular pathways in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

PHILADELPHIA, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: age associated neurodegenerative disease, age associated neurodegenerative disorder

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.